Document is current

Article History

Received: 24 May 2024

Accepted: 8 July 2024

First Online: 22 July 2024

Declarations

:

: Tiago Torres has received consultancy and/or speaker's honoraria from and/or participated in clinical trials sponsored by AbbVie, Almirall, Amgen, Arena Pharmaceuticals, Biocad, Biogen, Boehringer Ingelheim, Bristol Myers Squibb, Celgene, Fresenius Kabi, Janssen, LEO Pharma, Eli Lilly, MSD, Mylan, Novartis, Pfizer, Samsung-Bioepis, Sanofi-Genzyme, Sandoz and UCB. Maria João Cruz has received consultancy and/or speaker's honoraria from AbbVie, Almirall, Beiersdorf, Eli Lilly, Galderma, La Roche-Posay, LEO Pharma, Novartis, Pfizer, Pierre Fabre, Regeneron Pharmaceuticals Inc.and Sanofi. Margarida Gonçalo was a speaker or advisor for Abbvie, Astrazeneca, Eli Lilly, Leo Pharma, Novartis, Pfizer, Sanofi and Takeda. Bruno Duarte has received speaker and/or consultant fees from Sanofi, Eli-Lilly, Abbvie, Pfizer, Leo, Galderma and Janseen. João Alves has received consultancy and/or speaker’s honoraria from AbbVie and Galderma. Alberto Mota has received consultancy and/or speaker's honoraria from AbbVie, Eli Lilly and Co., LEO Pharma, and Sanofi-Genzyme. Paulo Filipe, José Miguel Alvarenga, Gilberto Rosa, Duarte Flor, José Ramos, Diogo Sousa, Aureliu Rosca, César Magalhães, Cristina Claro, Joana Rocha, Catarina Vilarinho, Fernando Mota, and Maria João Paiva Lopes declare no conflicts of interest.

: The present study was conducted in accordance with the Declaration of Helsinki initially published in 1964 on Ethical Principles for Medical Research Involving Human Subjects and after approval by the local ethical committees. Patients consent was exempted due to the retrospective nature of the study: the study protocol did not deviate from standard clinical practice, and data collection and handling complied with applicable laws, regulations, and guidance regarding patient protection, including patient privacy.